Cargando…
Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket
The DNA binding domain (DBD) of the tumor suppressor p53 is the site of several oncogenic mutations. A subset of these mutations lowers the unfolding temperature of the DBD. Unfolding leads to the exposure of a hydrophobic β-strand and nucleates aggregation which results in pathologies through loss...
Autores principales: | Pradhan, Mohan R, Siau, Jia Wei, Kannan, Srinivasaraghavan, Nguyen, Minh N, Ouaray, Zohra, Kwoh, Chee Keong, Lane, David P, Ghadessy, Farid, Verma, Chandra S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393305/ https://www.ncbi.nlm.nih.gov/pubmed/30649466 http://dx.doi.org/10.1093/nar/gky1314 |
Ejemplares similares
-
Inhibition of Nutlin-Resistant HDM2 Mutants by Stapled Peptides
por: Wei, Siau Jia, et al.
Publicado: (2013) -
Conformational landscape of the epidermal growth factor receptor kinase reveals a mutant specific allosteric pocket
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2018) -
Long range recognition and selection in IDPs: the interactions of the C-terminus of p53
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2016) -
In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition
por: Wei, Siau Jia, et al.
Publicado: (2013) -
Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides
por: Wei, Siau Jia, et al.
Publicado: (2016)